UNSPSC 51284136: Cefotaxime sodium

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 258J72S7TZ. European Medicines Agency schedules Cefotaxime sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13276MIG. Cefotaxime sodium generally arises in the molecular formula C16H16N5NAO7S2. The term 'cefotaxime sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cefotaxime sodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFOTAXIME SODIUM remains US FDA's Preferred Term for this commodity. Cefotaxime sodium bears US NLM identifiers UMLS ID C0700445 and NCI Concept Code C2328. SMILES: CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3CSC(N3)N)SC1)C(=O)[O-].[NA+].

UNSPSC 51284136 Cefotaxime sodium is a Commodity code representing a specific pharmaceutical product, but recent state and local procurement activity under this code shows minimal direct alignment with the nominal scope. The most recent opportunities tagged to this code actually solicit broader medical supply categories, naloxone and drug deactivation systems, emergency response consumables, and generic pharmaceutical contracts through cooperative purchasing vehicles — not cefotaxime specifically. State and local buyers using this code appear to be health departments, fire and rescue divisions, and state pharmacy benefit programs sourcing pharmaceuticals and medical consumables through competitive bidding, RFP, and cooperative purchasing arrangements rather than single-product procurement.

Recent activity spans Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering a statewide RFP for generic multi-source pharmaceuticals and OTC products due March 26, 2026, serving participating state and local government facilities across multiple states including Oregon. Seminole County, Florida issued an IFB (Solicitation IFB60459723LAS) on June 30, 2026, for naloxone and drug deactivation systems with a response deadline of July 26, 2023. The City of Tampa's Purchasing Department solicited medical and first aid supplies for the Tampa Fire Department Rescue Division (Bid 26-P-00145) due March 13, 2026, with an estimated contract value of $700,000 and a 5% bid discount available for certified Small Local Business Enterprises. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The code's recent procurement footprint is fragmented across health systems, emergency services, and state pharmacy benefit programs, but shows no concentrated activity specifically targeting cefotaxime as a line item.